Close

89bio Inc. (ETNB) Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin

Go back to 89bio Inc. (ETNB) Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin

89bio Inc. (ETNB) Halted, News Pending

June 28, 2022 4:00 PM EDT

89bio Inc. (NASDAQ: ETNB) Halted, News Pending

... More